PLOS Medicine Submission Process
PLOS Medicine's submission process, first-decision timing, and the editorial checks that matter before peer review begins.
Readiness scan
Before you submit to PLOS Medicine, pressure-test the manuscript.
Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.
Key numbers before you submit to PLOS Medicine
Acceptance rate, editorial speed, and cost context — the metrics that shape whether and how you submit.
What acceptance rate actually means here
- PLOS Medicine accepts roughly ~15% of submissions — but desk rejection runs higher.
- Scope misfit and framing problems drive most early rejections, not weak methodology.
- Papers that reach peer review face a different bar: novelty, rigor, and fit with the journal's editorial identity.
What to check before you upload
- Scope fit — does your paper address the exact problem this journal publishes on?
- Desk decisions are fast; scope problems surface within days.
- Open access publishing costs $5,900 USD if you choose gold OA.
- Cover letter framing — editors use it to judge fit before reading the manuscript.
How to approach PLOS Medicine
Use the submission guide like a working checklist. The goal is to make fit, package completeness, and cover-letter framing obvious before you open the portal.
Stage | What to check |
|---|---|
1. Scope | Presubmission inquiry (optional but recommended) |
2. Package | Full manuscript preparation |
3. Cover letter | Online submission through Editorial Manager |
4. Final check | Editorial assessment and triage |
Quick answer: This PLOS Medicine submission process guide explains the two-stage workflow that most authors do not fully understand. The initial submission is fast and lightweight. If editors want the paper, they request a full submission.
Use the initial submission as a real-time fit test, not as a formality.
PLOS Medicine runs its workflow on Editorial Manager, but the portal only moves files between you, the editors, and the reviewers; it never tells you whether your paper clears the fit bar. That gap is the whole problem this page solves.
The initial submission screen turns on one judgment the portal cannot make for you: does the structured abstract, the cover-letter opening, and the data-availability posture prove an international clinical or health-policy consequence before you invest in full formatting?
Editors decline about half of initial submissions within two weeks, almost always on significance and scope rather than on formatting, so the productive work happens before you ever click submit. The sections below walk each stage, name what must be ready at each point, and translate every editorial signal into a concrete next action.
This guide tells you what PLOS Medicine editors look for before the full-submission request, and Manusights checks whether your paper passes the international clinical significance, health-policy consequence, structured abstract, reporting-checklist, data-availability, ethics, trial-registration, and specialty-journal routing checks that the official PLOS process pages cannot evaluate from a generic checklist. Paid Manusights reviews are covered by a 60-day money-back guarantee, and we never train on submitted manuscripts.
What does the PLOS Medicine submission process involve?
This page owns the process question: what happens at each PLOS Medicine stage, what the author must have ready, and what each editorial signal means. For broader journal fit, use the separate PLOS Medicine submission guide.
PLOS Medicine uses a two-stage submission system. Stage 1 is the initial submission: a streamlined package that lets editors assess fit quickly. About half of submissions are declined at this stage within 2 weeks. Stage 2 is the full submission: editors request this if the paper is promising. Full peer review follows, with 2 to 3 reviewers and time to first decision typically 6 to 8 weeks.
The acceptance rate is roughly 15%. The journal uses single-anonymous peer review by default but offers options for signed and published peer review.
Day | What happens | Author action |
|---|---|---|
Day 0 | Initial lightweight submission uploaded for editorial screening | Submit manuscript text and structured abstract |
Days 1 to 14 | Editors assess international clinical and health-policy significance; about half are declined here | Wait for the fit decision |
Days 14 to 21 | If promising, editors request a full formatted submission | Begin assembling the full package |
Days 21 to 35 | Full submission assembled and routed to peer review | Upload complete materials, checklist, and data |
Days 35 to 63 | 2 to 3 expert reviewers evaluate the manuscript | Respond to any editor queries |
Days 56 to 84 | First decision returned: accept, revise, or reject | Plan revisions or resubmission |
Before submitting to PLOS Medicine, a PLOS Medicine manuscript fit check identifies whether the package meets the editorial bar before you commit to the submission.
What key PLOS Medicine metrics matter?
Metric | Value |
|---|---|
Impact Factor (JCR 2024) | 9.9 |
Acceptance rate | ~15% |
Submission system | |
Publisher | PLOS |
How was this page built?
How this page was created: we reviewed PLOS Medicine submission guidelines, the editorial and peer-review process, current issue patterns, and Manusights pre-submission review notes for manuscripts targeting PLOS Medicine.
We reviewed the 100 most recent PLOS Medicine papers used when this process guide was built, including DOI spot-checks such as 10.1371/journal.pmed.1004918, 10.1371/journal.pmed.1004871, and 10.1371/journal.pmed.1004930. We compared those accepted-paper patterns with recent manuscripts that were looking to submit to this journal through our Manusights work reviews.
Manusights internal analysis identifies a failure pattern: authors often treat the initial submission as an upload shortcut, but PLOS Medicine uses it as a serious editorial fit test for international clinical, public-health, or policy significance.
In our analysis of PLOS Medicine process failures, we find that editors specifically screen the first abstract, cover-letter sentence, and data-availability posture for whether the manuscript can support a broad clinical or health-policy decision before the author invests in full formatting.
Source limitation: PLOS explains the mechanics of submission and peer review, but it does not tell authors whether their abstract, reporting checklist, data plan, or global-health framing is strong enough to pass the first editorial read. The useful process decision is what must be fixed before Stage 1 versus what can wait until a full submission request.
What stage-by-stage readiness checklist should authors use?
Stage | What should be ready | What can break the process |
|---|---|---|
Initial submission | Clear abstract, author metadata, core figures or tables, and a concise fit argument | Abstract reads like a specialty-clinical paper with no international or policy consequence |
Editorial screening | One sentence explaining why the finding matters beyond one local setting | Editors cannot see why PLOS Medicine is the right venue before full formatting |
Full submission request | Reporting checklist, data availability statement, ethics approvals, trial registration, and complete supplements | Authors wait until the request arrives before preparing data or checklist materials |
Peer review | Methods, statistics, and interpretation already aligned with the relevant reporting standard | Reviewers find that conclusions outrun the study design or the evidence is not reusable |
How does the two-stage process work?
Stage 1: Initial Submission and Initial Quality Check
The initial submission is intentionally lightweight. You upload a complete manuscript text, but detailed formatting, final supplementary materials, and polished reference styling are not required.
This stage exists so you can get editorial feedback without the overhead of full formatting. PLOS Medicine will tell you within 2 weeks whether the work fits the journal. If it does not fit, you have lost minimal preparation time.
To submit, go to the PLOS Medicine submission portal. Create or log into your PLOS account. The corresponding author needs an ORCID.
Include:
- manuscript text with structured abstract (300 to 500 words)
- author list with CRediT contributions
- figures and tables
- cover letter (optional but recommended)
Do NOT include at this stage:
- final supplementary materials (unless they are ready)
- detailed PLOS formatting
- polished reference style
Stage 2: Full submission
If editors want to move forward, they request a full submission. At this point, you need:
- complete manuscript formatted per PLOS Medicine guidelines
- all supplementary materials
- fully completed reporting checklist (CONSORT, STROBE, PRISMA, etc.)
- data deposited in a public repository with accession numbers
- complete ethics declarations and conflict of interest statements
- trial registration number (if applicable)
The full submission goes to peer review.
Decision risks before submitting to PLOS Medicine: failure patterns
Across Manusights submission reviews for clinical, public-health, and policy manuscripts targeting PLOS Medicine, three substantive patterns surface repeatedly across submissions that the journal's editors can identify during the initial submission screen. (Per PLOS Medicine's published submission guidelines, the journal uses an initial submission process so authors can submit quickly and receive rapid editorial feedback before completing the full submission package.
If editors commit to peer review, authors then complete a full submission with additional author details, reporting information, and supporting materials. Manusights internal analysis treats the structured abstract, first cover-letter sentence, reporting checklist, data-availability statement, ethics approval, trial registration, figures, tables, and nearby-journal routing as the practical pre-upload screen.) These are testable against your own manuscript before you treat the initial submission as a formality.
The three failure patterns we flag most often are a significance-blind initial submission, full-submission artifacts postponed until after the request, and a specialty manuscript stretched into a broad-medicine narrative.
Initial package lacks global significance
Across PLOS Medicine-targeted manuscripts, the most common process mistake is treating the initial submission as a lightweight administrative upload rather than as the first real editorial fit test. The official PLOS process makes the initial submission fast, but speed does not lower the significance bar.
Editors still need to see from the structured abstract, cover-letter opening, figures, tables, study design, and limitations paragraph why this work belongs in PLOS Medicine rather than in a specialty clinical journal, PLOS Global Public Health, BMJ, Lancet Global Health, eClinicalMedicine, JAMA Network Open, or PLOS ONE.
Manuscripts often fail this screen when the clinical result is valid but the consequence is local, operational, or disease-specialty specific: one hospital policy, one national reimbursement environment, one biomarker cohort, one implementation site, or one specialty service line. The fix is not heavier formatting.
It is a clearer Stage 1 argument: name the clinical or health-policy decision the paper changes, show why the decision travels across health systems, connect the figures to the decision, and make the data-availability and reporting posture visible before the editor has to infer readiness.
Check whether your PLOS Medicine initial submission makes the broad significance case →
Full-submission artifacts postponed until after editors request the complete package
In our Manusights editorial analysis, PLOS Medicine process problems also appear when authors plan to finish the reporting checklist, ethics statement, trial registration details, data repository deposit, code availability note, figure legends, supplementary methods, and author contribution disclosures only after receiving a full-submission request. That sequencing creates a false sense of efficiency.
The initial submission can be streamlined, but the editor still reads for whether the study will survive the full PLOS Medicine transparency standard.
If the structured abstract promises a clinical decision but the methods section does not show the relevant reporting guideline, if a clinical trial lacks a visible registration posture, if observational work does not map clearly to STROBE, if a systematic review does not map to PRISMA, or if the data-availability statement is vague, the process risk is not formatting delay.
The risk is that the editor cannot trust the package will be ready for peer review. The practical fix is to build the full-submission skeleton before Stage 1: checklist chosen, ethics language stable, trial registration confirmed, data statement drafted, supplemental files mapped, and the cover letter honest about any access limits.
Check whether your PLOS Medicine reporting and data package is ready before Stage 1 →
Specialty-journal manuscript stretched into a PLOS Medicine process narrative
The third recurring pattern is a manuscript that is clinically serious but has a cleaner home elsewhere. PLOS Medicine is not simply a high-prestige endpoint for any strong medical paper; the process is built around broad medical, public-health, and policy consequence.
A paper may be excellent and still fit BMJ, JAMA Network Open, Lancet Regional Health, Lancet Global Health, eClinicalMedicine, Clinical Infectious Diseases, Circulation, Neurology, Diabetes Care, Gut, or a specialty society journal better than PLOS Medicine.
The mismatch usually appears in the components editors see first: the title names a specialist population, the abstract outcome matters mainly to a niche clinic, the methods answer a technical question rather than a health-system question, the figures support a specialty recommendation, and the cover letter relies on general importance language rather than a specific international decision. The fix is to route honestly.
If PLOS Medicine is still the right target, rewrite the initial package around the policy or practice decision, the population-level implication, the reporting standard, and the data-reuse value. If not, choose the venue whose reader can act on the result fastest.
Check whether your PLOS Medicine paper should route to a specialty journal instead →
Readiness check
Run the scan while PLOS Medicine's requirements are in front of you.
See how this manuscript scores against PLOS Medicine's requirements before you submit.
Editorial Triage: What Happens During Screening
The initial submission goes to PLOS Medicine's senior editors. They evaluate whether the paper should move to full submission and peer review.
Editors are asking:
- does this work directly inform clinical practice or health policy?
- are the findings relevant beyond one national context?
- is the study design strong enough to support the claims?
- is the topic relevant to PLOS Medicine's international readership?
- does the work represent a substantial advance over what is already known?
About half of all initial submissions are declined at this stage. The decline is typically fast (1 to 2 weeks) and includes brief feedback explaining why the paper does not fit.
If editors are uncertain, they may consult an academic editor with relevant expertise before deciding. This can add a few days to the screening timeline.
What happens during peer review?
Full submissions go to 2 to 3 expert reviewers selected for their expertise in the study's clinical area and methodology. PLOS Medicine uses single-anonymous review by default (reviewers are anonymous, authors are visible). Authors can opt into open peer review where reviewer identities are disclosed and published alongside the article.
Reviewers evaluate:
- significance for clinical practice or health policy
- methodological rigor and study design
- appropriateness of statistical analysis
- completeness of reporting (against the relevant guideline)
- data availability and transparency
- whether the conclusions match the evidence
The review timeline is typically 4 to 6 weeks, though a complex methodology or statistical review, or a slow reviewer, can extend that as an edge case. First decisions from peer review arrive 6 to 8 weeks after the full submission.
Editorial Decision: How to Interpret It
Decision | What it means | What to do next |
|---|---|---|
Accept | Rare on the first round; usually follows revision | Final checks and proofs |
Minor revision | Specific changes requested; the paper is close to publication | Address each point precisely and resubmit |
Major revision | Substantive concerns about methodology, analysis, or interpretation; the revised paper returns to reviewers | Re-run or reframe, then resubmit with a response letter |
Reject after review | The paper does not meet the threshold despite passing initial screening; the letter includes reviewer feedback | Route to a better-fit journal using that feedback |
Reject at initial submission | The paper does not fit PLOS Medicine's scope or significance standard; brief editorial feedback is provided | Reframe the significance case or choose a specialty venue |
What published peer review option does PLOS Medicine offer?
PLOS Medicine offers the option to publish peer reviews alongside the accepted article. If authors and reviewers both consent, the reviewer reports are published with the paper. This is optional and does not affect the editorial decision.
What common process mistakes matter?
- Failure pattern: treating the initial submission as a full submission. Some authors spend weeks perfecting formatting before the initial submission. This misses the point of the two-stage system. Get the science right, present it clearly, and let the editors assess fit before you invest in formatting details.
- Failure pattern: submitting without the global health angle. PLOS Medicine is not a general clinical journal. It specifically prioritizes work that informs clinical practice or health policy in international settings. A strong clinical trial that is primarily relevant to one health system may be better suited to BMJ or a specialty journal.
- Failure pattern: not having data ready when the full submission is requested. If editors request a full submission, you need the data deposited and the availability statement finalized. Do not wait until the full submission request to start the data deposit process. Prepare the data plan alongside the manuscript.
- Failure pattern: missing the reporting checklist at full submission. The initial submission does not require a finalized reporting checklist. The full submission does. If the editors request a full submission, have the CONSORT, STROBE, or PRISMA checklist ready to include.
Pre-submission checklist
Before you click submit on the initial submission, confirm each item below. None of these requires full formatting, but each one is what an editor reads for during the Stage 1 fit screen:
- The structured abstract states an international clinical or health-policy decision, not just a local result
- The opening cover-letter sentence names the decision the paper changes and why it travels across health systems
- The study design clearly maps to the relevant reporting standard (CONSORT, STROBE, or PRISMA)
- A data-availability plan exists, with a target repository identified even if deposit is not yet complete
- Ethics approval and trial registration language is stable and ready to finalize on a full-submission request
- The figures and tables support a broad-medicine claim rather than a specialty-journal claim
Run a PLOS Medicine pre-submission readiness check to test the package against these signals in about 1 to 2 minutes before you treat the initial submission as a formality.
How does PLOS Medicine compare to nearby alternatives?
Feature | PLOS Medicine | PLOS ONE | BMJ | Lancet Global Health |
|---|---|---|---|---|
Review model | Significance + global relevance | Soundness only | Significance + clinical impact | Significance + LMIC focus |
Two-stage submission | Yes (initial + full) | No (single stage) | No (single stage) | No (single stage) |
Acceptance rate | ~15% | ~31% | ~7% | ~10% |
Open access | Yes | Yes | Hybrid | Yes |
Review speed | 6 to 8 weeks (from full) | 35 to 45 days | 4 to 6 weeks | 4 to 6 weeks |
Best for | Global health, clinical practice, health policy | Broad, soundness-focused | Clinical practice in broad medicine | Global health in LMIC settings |
Choose when | The work matters globally and benefits from rapid editorial fit assessment | Data sharing is central and significance filtering is not needed | The audience is broad clinical practitioners | The primary contribution is to LMIC health |
Submit If
- the study has clear implications for clinical practice or health policy across health systems
- you want rapid editorial feedback on fit before investing in full formatting
- the reporting checklist is complete or nearly complete
- the data availability plan is concrete
- the work is relevant to an international audience, not just one national context
Think Twice If
- the abstract names PLOS Medicine, but the stated clinical consequence is mainly relevant to one country, institution, or narrow specialty setting
- the methods section is translational, mechanistic, or biomarker-focused without a direct clinical-practice or health-policy decision
- the data availability statement, ethics approvals, trial registration, or reporting checklist cannot be completed quickly if full submission is requested
- the figures and tables support a specialty-journal claim more clearly than a broad international medicine claim
- the cover letter explains importance in general terms but does not state what PLOS Medicine readers should do differently after reading the paper
Before you submit, run a PLOS Medicine submission readiness check. It takes about 1-2 minutes and evaluates methodology, citations, and journal fit.
What related resources support this process page?
Frequently asked questions
PLOS Medicine uses a two-stage submission process. The initial submission is fast and lightweight - if editors want the paper, they request a full submission. This saves you from investing in detailed formatting for a paper that might not fit. Use the initial submission as a real-time fit test.
PLOS Medicine makes initial screening decisions quickly based on the lightweight first-stage submission. Full review timelines begin after editors request a full submission from papers that pass the initial fit test.
PLOS Medicine has a high desk rejection rate at the initial submission stage. The two-stage process is designed so that most papers are screened before authors invest in detailed formatting. Papers without clear general-medicine significance are declined early.
After the initial lightweight submission, editors assess fit and significance. If they want the paper, they request a full submission with detailed formatting. This two-stage process saves authors from formatting work on papers that do not fit the journal's scope for broad clinical and policy significance.
Sources
Final step
Submitting to PLOS Medicine?
Run the Free Readiness Scan to see score, top issues, and journal-fit signals before you submit.
Target journal carried over: PLOS Medicine
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- PLOS Medicine Submission Guide: What to Prepare Before You Submit
- How to Avoid Desk Rejection at PLOS Medicine
- PLOS Medicine Pre Submission Checklist: 12 Items Editors Verify Before Peer Review
- PLOS Medicine Review Time: What Authors Can Actually Expect
- PLOS Medicine 'Under Review': What Each Status Means and When to Expect a Decision
- PLOS Medicine Impact Factor 2026: 9.9 - A Top-Tier Open Access Medical Journal